Dose-response percentages of NiO-NPs in the studied groups. حسب Saeed El-Ashram (710370)

الموضوعات:

A semithin section of abnormal midgut epithelium. حسب Saeed El-Ashram (710370)

الموضوعات:

Fig 8 - حسب Saeed El-Ashram (710370)

الموضوعات:

Fig 4 - حسب Saeed El-Ashram (710370)

الموضوعات:

Cumulative mortality percentage in the studied groups during the studied period. حسب Saeed El-Ashram (710370)

الموضوعات:

Fig 5 - حسب Saeed El-Ashram (710370)

الموضوعات:

Trace metal percentages (%) in midgut tissues of <i>B</i>. <i>polycresta</i> of the studied groups. حسب Saeed El-Ashram (710370)

الموضوعات:

Fig 3 - حسب Saeed El-Ashram (710370)

الموضوعات:

Variants in the three-way intersections of credible sets predicetd to alter chromatin accessibility in brain cell types. حسب Daniela Fusco (10027975)

الموضوعات:

Statistically significant linear increase in use of antidepressants during the observed time period. حسب Jelena Filimonovic (22305307)

الموضوعات:

MAF1 protein expression by patient race and age. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

Analysis of MAF1 as a candidate predictive biomarker in HER2-positive breast cancer. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

MAF1 protein expression by stage and tumor histology. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

MAF1 and TFIIIB are differentially expressed in response to the CDK4/6 inhibitor abemaciclib. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

Top ten neratinib-treated sensitive (upper panel) and resistant (lower panel) CTRP breast cancer cell lines. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

KEGG pathway analysis for MAF1. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

Datasets analyzed. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

Clustered heatmaps for GSE129254, GSE158969, GSE15783, and GSE99060 datasets. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

MAF1 amplification frequently occurs in breast cancer patients. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات:

MAF1 and TFIIIB are differentially expressed in response to anti-HER2 therapies. حسب Stephanie Cabarcas-Petroski (9631636)

الموضوعات: